NVTA - Invitae Corp Stock Price, Fair Value and News

$6.700.00 (0.00%)

Market Closed

NVTA Stock Valuation Analysis

Valuation

Max Portfolio %

NVTA Price Action

NVTA RSI Chart

NVTA Stock Valuation Analysis

Valuation

Max Portfolio %

NVTA Valuation

NVTA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NVTA Fundamentals

NVTA Revenue

NVTA Earnings

NVTA Profitability

NVTA Investor Care

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	510.0M	493.9M	481.6M	0
2022	480.5M	500.8M	520.0M	516.3M
2021	319.0M	389.1M	434.8M	460.4M
2020	240.5M	233.2M	245.5M	279.6M
2019	160.6M	176.8M	195.9M	216.8M
2018	85.6M	108.5M	127.7M	147.7M
2017	31.4M	40.2M	52.1M	68.2M
2016	11.1M	14.9M	19.0M	25.0M
2015	2.7M	4.2M	6.1M	8.4M
2014	512.0K	876.0K	1.2M	1.6M
2013	0	0	0	148.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Invitae Corp

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

CEO	Mr. Kenneth D. Knight
WEBSITE	invitae.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	1700